2018 PDA Biosimilars Workshop
2018 PDA Biosimilars Workshop
Getting it Right the First Time for Biosimilar Marketing Applications
Over two days, noted industry experts and speakers from the U.S. FDA, EMA, Health Canada, and the Medicines Evaluation Board (MEB) in The Netherlands will share the most common challenges they’ve identified in biosimilar applications, both in established requirements and in more progressive areas, such as statistical tools. Gain practical approaches to tackle technical obstacles and avoid the pitfalls frequently encountered during biosimilar candidate development!
Leave a Reply